Literature DB >> 26538735

Chronic Myeloid Leukemia Arising in a Patient of Neurofibromatosis Type 1.

Sushma Rajesh Gulhane1, M N Kotwal2.   

Abstract

Neurofibromatosis type 1 (NF1) represents a major risk factor for development of malignancies, particularly malignant peripheral nerve sheath tumors (MPNST), optic gliomas, other gliomas, and leukemia. We report an unusual case of chronic myeloid leukemia (CML), developed in a patient of NF1. A 40-year-old Indian male, clinically manifesting NF1 since his childhood, presented with huge splenomegaly. Patient also had a large tumor mass arising in a café-au-lait spot on lower back with rapid growth in last 6 months. Excision of this tumor was done, and it turned out to be a diffuse neurofibroma histologically. Peripheral smear was also done in view of splenomegaly, which showed features of chronic myeloid leukemia. CML rarely co-exists with NF1, and there are a very few reports of such cases. It is important to be aware of the possibility that not only the malignant change in benign PNST is more common in these patients, but also other malignancies like CNS tumors and hematolymphoid neoplasm do occur with increased frequency.

Entities:  

Keywords:  Chronic myeloid leukemia; diffuse neurofibroma; neurofibromatosis type 1

Year:  2015        PMID: 26538735      PMCID: PMC4601456          DOI: 10.4103/0019-5154.164443

Source DB:  PubMed          Journal:  Indian J Dermatol        ISSN: 0019-5154            Impact factor:   1.494


  9 in total

Review 1.  Pathophysiology of neurofibromatosis type 1.

Authors:  Amy Theos; Bruce R Korf
Journal:  Ann Intern Med       Date:  2006-06-06       Impact factor: 25.391

2.  Diffuse large B-cell lymphoma arising in a patient with neurofibromatosis type I and in a patient with neurofibromatosis type II.

Authors:  Osamu Dohi; Masahito Hatori; Ryo Ichinohasama; Masami Hosaka; Sho Hashimoto; Shoichi Kokubun
Journal:  Tohoku J Exp Med       Date:  2006-02       Impact factor: 1.848

3.  Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms.

Authors:  S A Sørensen; J J Mulvihill; A Nielsen
Journal:  N Engl J Med       Date:  1986-04-17       Impact factor: 91.245

4.  Neurofibromatosis and childhood leukemia.

Authors:  J L Bader; R W Miller
Journal:  J Pediatr       Date:  1978-06       Impact factor: 4.406

5.  Chronic myeloid leukemia in an adult ghanaian with sporadic neurofibromatosis 1.

Authors:  Edeghonghon E Olayemi; Amma A Benneh; Michael E Acquah; Paul K Mensah
Journal:  Indian J Dermatol       Date:  2011-07       Impact factor: 1.494

Review 6.  Malignancy in neurofibromatosis type 1.

Authors:  B R Korf
Journal:  Oncologist       Date:  2000

7.  Juvenile chronic myelogenous leukemia, neurofibromatosis 1, and xanthoma.

Authors:  K A Jang; J H Choi; K J Sung; K C Moon; J K Koh; D J Im
Journal:  J Dermatol       Date:  1999-01       Impact factor: 4.005

8.  Chronic lymphocytic leukemia associated with von Recklinghausen neurofibromatosis.

Authors:  M Sanada; K Takai; H Shibuya; E Okazaki
Journal:  Int J Hematol       Date:  1991-10       Impact factor: 2.490

9.  Neurofibromatosis and childhood leukaemia/lymphoma: a population-based UKCCSG study.

Authors:  C A Stiller; J M Chessells; M Fitchett
Journal:  Br J Cancer       Date:  1994-11       Impact factor: 7.640

  9 in total
  1 in total

1.  Chronic Lymphocytic Leukemia in Neurofibromatosis Type 1 Patients: Case Report and Literature Review of a Rare Occurrence.

Authors:  Philip R Cohen
Journal:  Cureus       Date:  2021-04-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.